Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.35779 | 53 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.40832 | 56 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.36298 | 55 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.29907 | 54 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.78366 | 64 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.38403 | 53 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.37987 | 53 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.39551 | 56 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.31964 | 54 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.44876 | 57 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.36828 | 55 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.31035 | 54 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.35147 | 54 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.35056 | 55 |